Skip to content

Clinical trials

Macular Degeneration trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Country / region: Netherlands Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20074
20081
20092
20101
20111
20121
20152
20181
20193
20201
20212
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated5
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Maastricht University Medical Center3
Bayer2
Janssen Research & Development, LLC2
Novartis2
Allergan1
Association for Innovation and Biomedical Research on Light and Image1
Erasmus Medical Center1
Frank G. Holz1
Gyroscope Therapeutics Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration24
Geographic Atrophy6
Choroidal Neovascularization5
Retinal Diseases4
Eye Diseases3
Retinal Degeneration3
Vision Disorders3
Wet Macular Degeneration3
Retinal Vein Occlusion2
Anetoderma1

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.